Ownership
Private
Stage
Phase 1
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Small moleculeBiologicMonoclonal antibody

Inncelerex General Information

Inncelerex is a specialized CRO and drug development consultancy with deep expertise in clinical pharmacology, pharmacometrics, modeling & simulation, pre-clinical safety/toxicology, and translational medicine. The team has contributed to the development and registration of numerous major medicines but does not have its own proprietary clinical pipeline. Instead, it provides expert services to biotech and pharma companies across all stages of drug development from candidate selection through early clinical trials.

Contact Information

Primary Industry
Contract Research Organization
Corporate Office
,
United States

Drug Pipeline

No pipeline data available

For full access to Inncelerex's pipeline data

Book a demo

Key Partnerships

Works with biotech/pharma clients globally.

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Inncelerex Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Inncelerex's complete valuation and funding history, request access »

Inncelerex Financial Metrics